Copyright 2024
| PMID | Allele | Disease | Population | Drug Names | SNP | Class | Sentence |
|---|---|---|---|---|---|---|---|
| 1558026 | HLA-B*27 | iridocyclitis | NA | NA | NA | unclassified | |
| the author experienced a 34-year-old male case of acute iridocyclitis with fibrinous exudates accompanied by ankylosing spondylitis with negative hla-b27. | |||||||
| 1558026 | HLA-B*27 | ankylosing spondylitis | NA | NA | NA | unclassified | |
| the author experienced a 34-year-old male case of acute iridocyclitis with fibrinous exudates accompanied by ankylosing spondylitis with negative hla-b27. | |||||||
| 1558026 | HLA-B*27 | iridocyclitis | NA | NA | NA | positive+negation | |
| since the clinical picture of iridocyclitis observed in our case showed no difference with those of hla-b27 positive cases, iridocyclitis associated with ankylosing spondylitis is considered to be the same entity regardless of hla-b27 being present or not. | |||||||
| 1558026 | HLA-B*27 | ankylosing spondylitis | NA | NA | NA | positive+negation | |
| since the clinical picture of iridocyclitis observed in our case showed no difference with those of hla-b27 positive cases, iridocyclitis associated with ankylosing spondylitis is considered to be the same entity regardless of hla-b27 being present or not. | |||||||
| 1558026 | HLA-B*27 | ankylosing spondylitis | NA | NA | NA | unclassified | |
| the cause of ankylosing spondylitis was postulated to be a cross reaction between hla-b27 and a certain gram-negative bacillus. | |||||||
| 1625093 | HLA-DRB1*11 | iridocyclitis | NA | NA | NA | unclassified | |
| human leukocyte antigen-drb1*1104 in the chronic iridocyclitis of pauciarticular juvenile rheumatoid arthritis. | |||||||
| 1625093 | HLA-DRB1*11 | juvenile rheumatoid arthritis | NA | NA | NA | unclassified | |
| human leukocyte antigen-drb1*1104 in the chronic iridocyclitis of pauciarticular juvenile rheumatoid arthritis. | |||||||
| 1625093 | HLA-DQB1 (HLA-DQB1) | iridocyclitis | NA | NA | NA | positive | |
| only one split of human leukocyte antigen (hla)-dr5, hla-drb1* 1104, showed a statistically significant association with a risk of chronic iridocyclitis (chi-square value = 7.52; p = 0.036 adjusted; odds ratio 3.45); hla-dqa1* 0501 and hla-dqb1* 0301, both in linkage disequilibrium with hla-drb1* 1104, also were significantly associated with eye disease. | |||||||
| 1625093 | HLA-DQB1 (HLA-DQB1) | eye disease | NA | NA | NA | positive | |
| only one split of human leukocyte antigen (hla)-dr5, hla-drb1* 1104, showed a statistically significant association with a risk of chronic iridocyclitis (chi-square value = 7.52; p = 0.036 adjusted; odds ratio 3.45); hla-dqa1* 0501 and hla-dqb1* 0301, both in linkage disequilibrium with hla-drb1* 1104, also were significantly associated with eye disease. | |||||||
| 1625093 | HLA-DRB1*11 | iridocyclitis | NA | NA | NA | positive | |
| only one split of human leukocyte antigen (hla)-dr5, hla-drb1* 1104, showed a statistically significant association with a risk of chronic iridocyclitis (chi-square value = 7.52; p = 0.036 adjusted; odds ratio 3.45); hla-dqa1* 0501 and hla-dqb1* 0301, both in linkage disequilibrium with hla-drb1* 1104, also were significantly associated with eye disease. | |||||||
Copyright 2024